Chancellor Rachel Reeves Plans Targeted Action on Bills in Forthcoming Budget
Chancellor Reeves has announced she is preparing "targeted steps to address household expense pressures" in next month's Budget.
Speaking to media outlets, she noted that curbing inflation is a shared duty of both the government and the Bank of England.
The UK's price growth is projected to be the most elevated among the G7 industrialized countries this year and the following year.
Potential Energy Bill Interventions
It is understood the government could intervene to lower energy bills, for example by reducing the present 5% rate of VAT charged on energy.
A further possibility is to cut some of the government charges presently added to bills.
Budgetary Constraints and Analyst Expectations
The administration will obtain the next assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much room there is for these actions.
The consensus from most economists is that Reeves will have to declare tax rises or spending cuts in order to meet her declared debt limits.
Previously on the same day, analysis indicated there was a £22 billion deficit for the chancellor to address, which is at the more modest range of expectations.
"There's a joint job between the Bank of England and the government to further reduce some of the sources of price increases," the Chancellor told reporters in Washington, at the yearly gatherings of the IMF and global financial institution.
Revenue Pledges and Global Issues
While much of the focus has been on likely tax rises, the Treasury chief said the most recent information from the fiscal watchdog had not changed her pledge to campaign commitments not to raise tax levels on income tax, VAT or National Insurance.
She blamed an "uncertain global environment" with increasing geopolitical and commercial concerns for the fiscal tax moves, probably to be directed on those "wealthiest."
International Economic Disputes
Referring to concerns about the United Kingdom's commercial links with China she said: "Our national security invariably come first."
Last week's declaration by Chinese authorities to tighten export controls on critical minerals and other resources that are crucial for high-technology manufacturing led American leader the US President to propose an extra 100% import tax on imports from the Asian country, raising the possibility of an all-out commercial conflict between the two global powers.
The American finance chief labeled the Chinese move "economic coercion" and "a international production power grab."
Questioned on accepting the American proposal to join its dispute with China, the Chancellor said she was "very concerned" by China's measures and encouraged the Beijing authorities "not to put up barriers and limit trade."
She said the move was "damaging for the global economy and creates further headwinds."
"In my view there are fields where we must challenge Chinese policies, but there are also valuable chances to trade with Chinese markets, including banking sector and other areas of the economy. We've got to achieve that equilibrium appropriate."
The Treasury chief also confirmed she was working with G7 counterparts "regarding our own essential resources approach, so that we are more independent."
Health Service Medicine Costs and Funding
Reeves also admitted that the price the National Health Service pays for drugs could go up as a consequence of current discussions with the US government and its drugs companies, in return for lower tariffs and funding.
Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or scrapping operations in the United Kingdom, with some attributing the modest returns they are obtaining.
Last month, the Science Minister said the price the NHS spends on medicines would have to increase to stop firms and drug research funding departing from the United Kingdom.
The Chancellor told the BBC: "We have seen due to the payment system, that drug testing, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other EU nations."
"Our aim is to ensure that individuals receiving care from the NHS are can obtain the best critical drugs in the world. And so we are reviewing all of that, and... aiming to secure more funding into Britain."